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Abstract
Huntington's  disease  (HD)  is  a  dominantly  inherited  neurodegenerative  disorder
whose  characterstics  were  first  described  by  George  Huntington  in  1872.  Several
decades later, in 1993, the mutation behind this disease was found to be an unstable
expanded CAG repeat within exon 1 of the HTT gene localized on the short arm of
chromosome 4. The majority of HD patients carry more than 40 CAG repeats, which
become unstable and usually increase in size in successive generations and in tissues.
In  order  to  dissect  the  molecular  mechanisms  underlying  CAG  repeat  instability,
several  HD  mouse  models  have  been  created  in  the  1990s.  Significant  data  have
revealed that the absence of proteins from the mismatch repair (MMR) or the base
and nucleotide excision repair  decreased the  pathogenic  expansion‐biased somatic
mosaicism and/or intergenerational expansions. Some polymorphic variants of MMR
genes have also been associated with reduced somatic expansions. Since expansion‐
biased somatic mosaicism likely contributes to disease manifestations, these results
suggest that genetic modifiers of instability may also affect disease severity. In this
chapter,  we  provide  an  overview  of  the  data  recently  published  about  DNA
instability; the roles of genetic modifiers of trinucleotide repeat dynamics in mouse
models; and the possible therapeutic interventions.
Keywords: Huntington disease, DNA instability, mouse models, genetic modifiers,
MMR
1. Introduction
Expansions of repetitive DNA sequences, including trinucleotide repeats, are associated with
a large number of neurological and neuromuscular disorders, such as fragile X syndrome,
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myotonic dystrophy type 1 and Huntington's disease (HD) [1, 2]. In the healthy population,
the triplet repeat tract size varies between 5 and 30 repeats and is stable. In HD patients, the
pathogenic allele contains more than 40 repeats and becomes highly unstable and usually
increases in size in successive generations (intergenerational instability) and in somatic tissues
(somatic instability). Longer expanded alleles are associated with more severe forms of disease
and result in a decreasing age of onset from one generation to the next [1, 3, 4]. Among
trinucleotide repeat disorders, HD disease is the fourth reported.
1.1. Clinical picture of HD
Huntington's disease is an autosomal dominant neurodegenerative disorder with a worldwide
incidence varying from 0.1 to 10 per 100,000 people depending on the country. The estimation
of prevalence varies according to haplogroups studied: it is estimated from 2 to 7 per 100,000
in the Caucasians and only 0.1–1 per 100,000 in Asians and Africans [5, 6]. Adult‐onset
Huntington disease is the most common form of HD and usually presents in early middle life.
HD symptoms include uncontrolled movements such as chorea, progressive cognitive
impairment and neuropsychiatric manifestations. The rare early‐onset form of the disease also
called juvenile form presents more severe symptoms with rigidity and motor dysfunctions [7].
HD symptoms and severity vary greatly among family patients and between juvenile and adult
onset forms. Currently, no treatment is suitable to stop or reverse any form of HD.
1.2. Genetic of HD
HD is caused by an unstable expanded CAG repeat within exon 1 of the huntingtin (HTT) gene
also called HD or IT15 that localizes on the short arm of chromosome four, 4p16.3 [8]. The
normal HTT gene contains from 5 to 35 stable CAG repeats, while the majority of HD patients
have expanded repeats of above 40 CAG units that are fully penetrant. In rare cases, HD
symptoms are associated with small CAG repeats from 36 to 39 CAG, which show low
penetrance [9, 10]. Abnormal CAG repeat tracts become unstable in the germline, with a
striking tendency toward expansions. Because longer alleles are associated with more severe
form of HD, expansion‐biased intergenerational instability results in a decreasing age of onset
from one generation to the next, a phenomenon known as anticipation. Typically, 40–50 CAG
repeats correlate with later‐onset of HD, whereas a mutation greater than 50 CAG repeats
results in a juvenile form. Two large analyses in HD patients (360 and 440 individuals,
respectively) have reported a high negative correlation between the disease age of onset and
the inherited CAG repeat length [11, 12]. Intergenerational instability biased toward expan‐
sions provides the molecular basis for clinical anticipation observed in HD (Figure 1).
1.2.1. Intergenerational instability
The frequencies of expanded, unchanged and contracted alleles have been investigated by
directly comparing the length of the repeat tract in each parent with that is observed in their
progeny to estimate the degree of intergenerational instability in each set of HD cohort. Small
normal alleles with CAG repeat size ranging from 10 to 28 CAG are genetically stable with
germline mutation rates <1% per generation [13]. However, the mutation frequency rises
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dramatically with the increasing size of the allele. Indeed, a CAG repeat size change on
expanded allele in the range of 36–49 repeats occurs in >70% of transmissions from affected
parents to HD children. A similar rate of expansion was found between multiethnic cohorts
[13–19]. In the two largest cohorts (>250 parent‐offspring pairs), the frequency of expansions
was estimated to be 52.1% in a multiethnic HD population and 67.3% in the Dutch cohort,
whereas only 18.1% and 25.2% contractions were observed, respectively [13, 18]. For individ‐
uals carrying more than 49 CAG repeats, the mutation rates go up to >95% per generation [14,
20]. In all cases, the frequency of expansions always exceeds the frequency of contractions in
HD populations. The instability of the CAG repeat between generations depends on the sex
of the transmitting parent and the length of the repeat itself. Studies of the two cohorts of HD
individuals with the mean size of ∼43 CAG repeats have shown that 61–68% of paternal
transmissions resulted in expansions, whereas the majority (>60%) of maternal transmissions
resulted in contractions or CAG stabilization [13, 18]. The largest expansions, associated with
the juvenile form of HD, are almost observed in male transmissions and are influenced by the
CAG repeat length of the transmitting parent [13]. The largest HD cohort study (337 trans‐
missions) has shown that the age of the transmitting parents and the sex of offspring do not
affect the intergenerational instability, suggesting that the gender of affected parents is the
Figure 1. CAG repeat dynamics in HD: features and implications of intergenerational and somatic instabilities.
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major modifier of intergenerational instability [18]. Repeat size variability has been investi‐
gated in spermatogonia, postmitotic spermatid and matura spermatozoa collected by laser
capture microdissection of testis from two HD patients in order to determine the timing of
repeat instability. Interestingly, CAG repeat expansions were already present before the end
of the first meiotic division and the frequency continues to increase in postmeiotic cell
population suggesting that the primary source of instability occurs in spermatogonia [21].
1.2.2. Somatic instability
Several studies have reported that the expanded CAG repeat allele is also unstable in somatic
tissues and increases in length over time [22–25]. Somatic CAG repeat size variation was
analyzed by bulk PCR in each tissue whereas the degree of somatic mosaicism was quantified
by a more sensitive PCR‐based approach called Small‐Pool PCR [26]. This method allows to
accurately assess the variation of CAG repeat length of each HD expanded allele in tissues,
using successive DNA dilutions in order to amplify few template molecules per reaction
(Figure 2A). The dynamics of somatic CAG repeat instability varies between and within tissues
with the highest instability observed in the striatum and cortex, two tissues that show the most
pronounced neuropathological abnormalities [22, 23, 25]. In a large Venezuelan HD cohort, a
positive correlation was reported between the size of progenitor alleles (inherited alleles) and
the expansion‐biased somatic mosaicism in buccal cells from individuals at the same age. This
observation suggests that the size of the inherited CAG repeat is an important modulator of
somatic instability [27]. Furthermore, it has been reported that CAG repeat expansion length
in the cortex is associated with an earlier age of disease onset suggesting that somatic instability
is a significant predictor of the age of onset [28]. Interestingly, somatic instability was not
observed in two fetuses at 12–13 weeks suggesting that the somatic expansion event occurs
later in the stages of fetal development or from birth throughout the patient's life [29].
Together, these data have clearly demonstrated the contribution of the sex of the transmitting
parent and the inherited length of the CAG repeat in the dynamics of intergenerational and
somatic instability in HD patients. Moreover, both germline and somatic mosaicism level
seems to be linked to the disease onset and to the progression of HD symptoms. Thus, aiming
at decreasing the size of expanded alleles or the level of somatic mosaicism would be an
attractive therapeutic strategy. In the majority of analyses, the degree of expansion length
variability between tissues and individuals cannot be explained only by the age, sex of the
transmitting parent and the progenitor allele size, therefore implying that genetic factors might
influence either germline or somatic instability. In 2012, the study of a large Portuguese HD
cohort has reported some HD families with extreme repeat length changes from parents to
offspring suggesting the existence of modifiers that may be heritable [19]. Hence, the under‐
standing of CAG repeat instability is crucial to improve the therapeutic possibilities. Analyses
of genetic modifiers of instability and dissection of mechanisms involved in this process are
compromised by the limited accessibility of human samples and clinical information. Then,
knockout, transgenic and knock‐in HD mouse models have been generated to dissect the
molecular mechanisms of instability and the pathogenesis of HD disease [30, 31].
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Figure 2. Methods to analyze CAG repeat length in germline and somatic tissues.
2. Mouse models of CAG repeat instability
The dynamics of expanded CAG repeat has already been analyzed in different simple
organism strains such as bacteria and yeast by inserting a plasmid with a pathogenic CAG
repeat. Analyses in E. coli and S. cerevisiae have provided valuable insight into factors affecting
the CAG repeat instability. However, these organisms displayed a CAG repeat instability
biased toward contractions in clear contrast to HD patients. Furthermore, both these organisms
differ from mammals by cellular processes such as DNA repair and replication pathways.
Therefore, mouse models have been generated to identify genetic modifiers of instability and
to specify the mechanisms by which they act in HD. These mouse models including two HD
transgenic mice with short gene fragment or BAC (R6 and BACHD), eight knock‐in (the
HdhQ20, HdhQ50, HdhQ92, HdhQ111, Hdh4/80, or Hdh6/72 lines, HdhQ150 and HdhQ80),
have been created to analyze the dynamic of CAG repeat instability in germline and somatic
tissues by different methods [24, 32–36] (Table 1). The first method determines CAG repeat
size by using unlabeled primers flanking CAG repeat. PCR and SP‐PCR products can be
resolved on agarose gel with internal size standards and detected with radioactive probes [37].
The second method measures the length of CAG tracts by using primers flanking CAG repeat
expansions, labeled with the 5‐carboxyfluoroscein fluorochrome. PCR products are electro‐
phoresed/separated in an automated sequencer together with internal size standards. In this
case, the sizing of the PCR fragment is determined using GeneMapper software that represents
the PCR fragments by peaks with single repeat unit resolution (Figure 2).
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Mouse
models
Genetic
background
Transgene CAG
repeat
length 
Mutation 
rate
Intergenerational 
instability (CAG
length variation)
Somatic
instability
(partial list)
References
Transgenic 
mice
BACHD FVB Human
HTT 
locus
97 None None None [34]
R6
(Excluded 
R6/T)
CBA/C57BL/6 Human
HTT 
exon 1
>110 65–84% Striatum>
kidney>
cerebellum
[32, 45, 46,
51, 52]
Knock‐in
mice
HdhQ80 C57BL6/J 80 ∼20% ↑ expansions (male
transmissions)
[35]
Hdh4/Q80 129Svter/
C57BL6
80 ∼20% ↓ contractions
(female
transmissions)
Striatum>
cerebellum>
liver 
[25, 36]
Hdh6/Q72 72 ∼20%
HdhQ50 48 4% Low None [54]
HdhQ20 CAG repeat
locus
18 None None [24]
HdhQ92 129SvEv/CD1 90 49% ↑ expansions (male
transmissions)
Striatum>
kidney>
cerebellum
[24, 56, 57]
HdhQ111 109 73% ↓ contractions
(female
transmissions)
[24, 56, 57,
58]
HdhQ150 C57BL6/129Ola 150 16% ND Striatum>
olfactory
bulb>
cerebellum
[25, 33, 38,
39]
Table 1. HD mouse models of CAG repeat instability.
BACHD mouse model was established by the introduction of a full‐length human htt locus
containing exon 1 with 97 mixed CAA‐CAG repeats in the FVB background. These mice do
not exhibit any repeat instability or contraction in germline and in brain tissues at 12 month
of age [34]. The stability of CAG triplet repeat results from the CAA interruption within the
CAG repeat tract, which probably modifies the DNA structure and then the repeat dynamics
[1]. Compared to BACHD mice, HdhQ150 knock‐in mice were generated by replacement of
the murine short CAG repeat in exon 1 with a 150 CAG repeat expansion in a mixed C57BL/
6/129Ola genetic background [33]. HdhQ150 animals reproduce somatic mosaicism in different
brain regions, most particularly in the striatum like HD patients [25, 38]. HdhQ150 mice
displayed some HD symptoms that seem more severe in homozygous mice [33, 39, 40].
Recently, heterozygous hdhQ250 mice have been generated from hdhQ150 by selective
breeding and shown more severe neurological symptoms than heterozygous hdhQ150 mice
[41]. Hdh4/Q80 and Hdh6/Q72 mice have also been obtained by replacement of short CAG
repeat with 72 or 80 CAG repeat expansions in htt murine gene context. Both these lines have
shown intergenerational instability biased toward expansions in paternal transmissions and
contractions in maternal transmissions like in HD patients. However, the mutation frequency
is only 20% across generations compared to 70% in HD individuals [36]. Hdh4/Q80 and Hdh6/
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Q72 have displayed somatic mosaicism that is tissue‐specific, age‐dependent and CAG repeat
length dependent [25, 36, 42, 43]. Some neurological and motor impairment have also been
described in these mice and might be correlated to the somatic mosaicism level [25, 36, 44]. A
different HdhQ80 mouse model has been created by replacement of the murin exon 1 with the
human exon 1 carrying ∼80 CAG repeat using C57BL6/J mice. Small expansions upon paternal
transmissions and CAG repeat contractions across maternal transmissions have been reported
in about 20% of cases. As observed in HdhQ150, Hdh4/Q80 and Hdh6/Q72, HdhQ80 mice have
shown somatic mosaicism that is age‐dependent and biased toward expansions with the
highest levels in the striatum and liver [35]. Compared to BACHD and knock‐in mice described
above, R6 and HdhQ111 mice are the most commonly used to identify the genetic modifiers
of CAG repeat instability [24, 32, 45]. Therefore, we will review the somatic and intergenera‐
tional instability features for both these animal models in the next section.
2.1. R6 transgenic mouse lines
The first successful HD transgenic mouse model was created in 1996 and called R6 lines of HD
transgenic mice [32]. These mice were obtained by random integration of a short 5’ fragment
of human HTT gene containing 1000 bp of 5’UTR, exon 1 with ∼130 CAG repeat tracts and the
beginning of intron 1 in a CBA/C57BL6 genetic background. Five lines of mice were obtained
with different insertion sites and CAG repeat lengths. The R6/T line carries a truncated HD
transgene without CAG repeat expansions, the R6/0 line carries 142 CAG repeats, R6/1 carries
116 repeats, the R6/2 carries 144 CAG and the R6/5 line carries multiple copies of transgene
with 128, 132, 135, 137 and 156 CAG repeats, respectively. R6/0 mice have shown no transgene
expression and no phenotype compared to R6/1, R6/2 and R6/5. These three mouse lines
develop progressively neurological abnormalities and show a variable age of onset that
depends on the CAG repeat length and on the transgene expression levels. R6/1 and R6/2 are
the most studied of these lines to assess both HD pathogenesis and CAG repeat instability.
To evaluate intergenerational CAG repeat lengths, fluorescent PCR using DNA from tail
biopsy at 3 weeks of age was performed in R6/0, R6/1, R6/2 parents and offspring. The
comparison of CAG repeat lengths between parents and their progeny is limited in R6/5 mice
due to the integration of multiple transgene copies in the genome of this line. Compared to
R6/1 and R6/2, R6/0 mice do not show any evidence of CAG repeat instability and any
transgene expression. As observed in HD patients, R6/1 and R6/2 mice mimic intergenerational
instability biased toward expansions across paternal transmissions and toward contractions
during R6/1 maternal transmissions (R6/2 female mice are infertile) with a mutation rate from
65 to 84% [45, 46]. Interestingly, the CAG repeat size changes depend on the gender of R6/1
embryos with a high expansion rate in males and high contraction rate in females from the
same fathers suggesting that offspring sex‐dependent genes modulate intergenerational
instability in R6/1 mice [46]. In R6/2 mice, the size of transmitted CAG expansion increases
with the age of transmitting males [45]. A selective R6/2 breeding enabled to obtain numerous
R6/2 colonies with inheriting CAG repeat ranging from ∼110 to 450 [47–49]. The size of CAG
repeat is positively correlated with the severity of symptoms up to ∼160 CAG repeats [47].
Surprisingly, some neurological symptoms and a lifespan are greatly ameliorated in R6/2 mice
Genetic Modifiers of CAG.CTG Repeat Instability in Huntington's Disease Mouse Models
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carrying more than 200 CAG repeat expansions [47–49]. These unexpected results can be
explained by transgene expression decrease observed in these mice [48]. A spontaneous
contraction from 116 to ∼89 CAG repeat was described in R6/1 mice [50]. These mice showed
a decreased age of onset and a HD phenotypic improvement compared to R6/1 mice with 116
CAG repeat supporting the relationship between the CAG repeat size and the progression of
symptoms.
Somatic instability of the CAG repeat tracts has been also reported in R6 lines carrying CAG
repeat expansions excepted for the R6/0 line [45]. R6/1 and R6/2 recreated expansion‐biased,
age‐dependent and tissue‐specific somatic mosaicism as observed in HD patients [38, 51, 52].
Liver and striatum have shown the highest levels of instability biased toward expansions
compared to other tissues that have shown low or no instability in both lines. Two distinct
modes of somatic expansion have been described in tissues from R6/1 mice. Striatum and cortex
have shown a periodic expansion, whereas the other tissues reproduce a short continuous
expansion overtime suggesting different mechanisms of instability in these tissues [51]. Large
spontaneous expansions (>200 CAG) have been described in striatum and cortex from R6/2
mice [52] consistent with the observations done in brain from HD patients [25, 43]. In R6/2
mice, the somatic mosaicism is correlated with the transmitted CAG repeat size but the somatic
variation is not linear, particularly in striatum [52]. Interestingly, the frequency of CAG
contractions increases in brain tissues and liver from mice with more than 500 CAG repeats
[52] and could also explain the progressive reduction of neurological symptoms and prolonged
lifespan in R6/2 mice with >200 CAG repeats [47–49]. Somatic instability has been noticed in
dividing cells suggesting a role of DNA replication in the dynamic of triplet repeat instability.
However, an increase of CAG repeat length has also been reported in terminally differentiated
neurons from R6/1 mice suggesting the role of cellular processes independent of DNA
replication in the somatic mosaicism [38]. Recently, an effect of mouse genetic backgrounds on
the dynamics of CAG expansions has been reported in tissues from R6/1 mice with high CAG
somatic mosaicism on a B6 background and low level in BALB/cBy backgrounds suggesting
the existence of genetic modifiers of instability [53].
2.2. HdhQ92‐111 mouse models
The first knock‐in mice called HdhQ50 have been generated in 1997 using homologous
recombination in ES cells to replace short murine CAG repeat by 48 CAG repeats in 129SvEv/
CD1 mice [54]. In 1999, three other knock‐in mouse models (HdhQ20, HdhQ92 and HdhQ111)
using the same strategy have been generated with 18, 90 and 109 CAG repeat tracts, respec‐
tively [24]. These four knock‐in mice share the identical murine genomic environment (91% of
similarities with HTT human) and differ only by the size of CAG repeat length. Knock‐in mice
with >50 CAG repeats reproduce the pattern of intergenerational instability observed in HD
patients. The mutation rate is only 4% in HdhQ50, 49% in HdhQ92 and 73% in the HdhQ111
supporting that intergenerational instability depends on CAG repeat length as described in
R6 mice [24]. However, no age effect has been observed in these knock‐in mice compared to
R6/2 [24]. These divergent results could be explained by the CAG repeat genomic context and
the genetic background. Interestingly, an effect of mouse genetic backgrounds on mutation
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rate and range of CAG repeat length changes upon male transmission was reported in
HdhQ111 supporting the role of genetic modifiers on CAG instability process [55].
Somatic CAG repeat variations have been observed in HdhQ92 and HdhQ111 mice in brain
and some peripheral tissues with the highest accumulation of expansions in striatum and liver
[24, 56, 57]. Both these tissues showed a bimodal distribution of repeat lengths compared to
spleen and tail that showed a unimodal distribution [56]. CAG expanded alleles were broadly
distributed in striatum compared to liver that showed distinct populations of CAG repeat
expansions [56]. Somatic instability depends on the CAG repeat size and the age of animals
and is tissue‐specific as reported in R6 mice [24, 56, 57]. The relationship between somatic
mosaicism and HD phenotype remains unclear but some data have reported that somatic
mosaicism is not correlated with the initiation of disease but may be correlated with the
progression of HD phenotypes [57, 58].
In conclusion, HD mouse models closely reproduced the dynamic of instability observed in
HD patients. Intergenerational instability is biased toward expansions and depends on the
CAG repeat length and the sex of transmitting parent. HD transgenic and knock‐in mouse
models also mimic the somatic instability of HD patients, with the highest somatic mosaicism
in the striatum that is the most affected tissue in HD. Some differences in the dynamics of
intergenerational instability between HD patients and HD mouse models can be noticed.
Despite a high level of instability biased toward expansions in paternal transmissions and
contractions in maternal transmissions in both species, the critical CAG repeat threshold length
differs between human and mice corresponding to 35 CAG repeats in human and more than
80 CAG repeats in mice. Moreover, no spontaneous large CAG repeat expansion has been
observed in HD mouse models during paternal transmissions, in contrast to HD patients. These
differences may be explained by genetic and environmental factors. Despite these divergences,
the development of HD mouse models provided a powerful tool to explore trinucleotide repeat
dynamics. Several data have suggested that the size, sex and the age factors are not sufficient
to explain the level of meiotic and mitotic instabilities observed in HD patients and mice
supporting the contribution of genetic modifiers in CAG repeat instability processes. Among
described mouse models, R6 and HdhQ111 were commonly used to investigate the role of
genetic modifiers on the level of intergenerational and somatic instability in HD.
3. Genetic modifiers of CAG repeat instability
The absence of correlation between CAG repeat somatic mosaicisms and the corresponding
tissue proliferative rates and the destabilization of CAG repeat in murine mature neurons
support the involvement of DNA repair pathways in the CAG repeat instability processes
(Table 2). To identify the DNA repair pathways involved in the germline and somatic CAG
repeat instability, R6/1 or HdhQ111 mice were crossed with mouse lines deficient for individual
DNA repair genes. CAG repeat length changes upon transmissions were determined by
comparing the CAG repeat size in the HD transmitting mice with CAG repeat length in the
HD progeny for each DNA repair genotype (+/+ to +/+ and ‐/‐ to ‐/‐ and/or +/‐ to +/‐). Further‐
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more, different methods have been described to quantify the degree of somatic instability and
have made it possible to compare the level of somatic mosaicism between HD mice mutated
and not for DNA repair genes [53, 57, 59–61].
Gene
modifiers
DNA
repair 
systems
Gene
status 
Mouse
models
Effect on CAG repeat length References
Intergenerational instability Somatic instability
Msh2 MMR KO HdhQ111 ↓ expansions ↑ contractions
(male transmissions)
CAG repeat
stabilization
[58, 67]
No change (female
transmissions)
R6/1 No expansion (male
transmissions) ND (female
transmissions)
↓ expansions [59, 63]
Msh3 HdhQ111 No significant change CAG repeat
stabilization
[64]
C57BL/6J R6/1 ND [53]
BALB/cByJ
Msh6 KO HdhQ111 No change (Msh6‐/‐) No change [64]
Mlh1 ND ↓ expansions [69]
Mlh3
Ogg1 BER R6/1 No change ↓ expansions [65, 70]
Neil1 ↓ expansions (male
transmissions)
[61]
Fen1 ND (female transmissions) No change [66]
Csb NER ↑ expansions ↓ contractions [65]
Xpc No change [64]
ND, not determined.
Table 2. DNA repair genetic modifiers involved in CAG repeat instability in mouse models.
3.1. Genetic modifiers of intergenerational instability
Despite some controversial results, the analyses in E. coli and S. cerevisiae suggested an effect
of mismatch repair (MMR) proteins on the dynamics of CAG repeat instability. MMR proteins
preserve genome integrity by repairing erroneous insertion, deletion and misincorporation of
bases that occur during replication and escape proofreading. Two MutS heterodimeres,
MutSα (MSH2‐MSH6) and MutSβ (MSH2‐MSH3) recognize replication errors and recruit
MutLα (MLH1‐PMS1/2) and MutLγ (MLH1‐MLH3) to activate the repair pathway [62]. The
breeding of HD mouse models in MMR‐deficient genetic backgrounds has provided insight
into the mechanisms of CAG repeat instability. In R6/1 mice, Msh2 deficiency abolishes CAG
Huntington's Disease - Molecular Pathogenesis and Current Models10
repeat expansion in the male germline suggesting that MSH2 promotes CAG repeat expansion
(no data for maternal transmissions) [59, 63]. A further study in HdhQ111 knock‐in mice
revealed that the effects of Msh2 mutation on the intergenerational dynamics seem to be more
complex. The absence of two Msh2 alleles suppresses the expansions in favor of contractions
without changing the mutation rate (corresponding to expansion and contraction frequencies)
in paternal transmissions [58, 64]. In contrast, a majority of contractions and a few expansions
were detected in female germline transmissions in both Msh2+/+ and Msh2‐/‐ backgrounds [24,
58]. Therefore, although MSH2 appears to be required in paternal CAG repeat expansions, the
CAG repeat gains in female germline and CAG repeat contractions seem to be generated by
Msh2‐independent processes [58]. MSH2 binding partners, MSH6 or MSH3, did not alter the
frequency of maternal changes, which is consistent with the lack of involvement of MSH2 in
female germline. The effects of MSH3 and MSH6 on paternal transmissions of the expanded
CAG repeat are more complex. The loss of Msh6 or Msh3 did not significantly affect the paternal
mutation frequencies and the frequency of expansions and contractions. However, a shift from
expansion to unchanged and contracted CAG repeat length is observed in Msh3‐/‐ or Msh3+/‐
transmissions compared to Msh3+/+ transmissions suggesting that some paternal expansions
might depend on MSH3 protein. These results together suggest that the majority of paternal
expansions occur via MSH2, independently of MSH3 and MSH6 partners in HdhQ111 mice
and that other DNA repair proteins are involved in CAG repeat parental expansions and
contractions observed in HD mice [64].
The involvement of base excision repair (BER) and nucleotide excision repair (NER) in CAG
repeat instability have been tested in R6/1 mice bred in a BER gene (Ogg1 or Neil1) and NER
gene (Csb or Xpc) deficient backgrounds. The loss of 7,8 dihydroxy‐8‐oxoguanin‐DNA‐
glycosylase, OGG1 did not affect the dynamic of instability in the germ cells [65]. However,
NEIL1, another glycosylase of BER contributed to paternal expansions in R6/1 mice. In the
absence of Neil1, the CAG repeat tracts were more stable with a tendency toward contraction
in male germline compared to Neil1+/+ [61]. Interestingly, an increase of CAG repeat expan‐
sions and a decrease of contractions in paternal transmissions have been observed in Csb‐
deficient mice suggesting that CSB promotes CAG repeat contractions during paternal
transmissions just like MSH2 promotes expansions in HD mouse models [65]. In contrast to
Cbs results, Xpc did not affect the dynamic of CAG repeat instability in R6/1 mice. It has also
been reported that FEN1, an endonuclease involved in the DNA replication but also in BER
intermediates, may stabilize CAG repeat in the Fen1+/‐ male germline by preventing deletions
and modestly increasing expansions but the effect seems to be low [66].
In conclusion, these data have shown that MSH2 and NEIL1 proteins are involved in the
formation of intergenerational repeat expansions in HD mouse models with the highest effect
of MSH2, suggesting that these genes are genetic modifiers of intergenerational instability in
HD. Moreover, the shift toward contractions observed in the absence of Msh2 and Neil1 reveals
that the repeat could be processed through a distinct pathway leading to contractions via CSB
or other DNA repair proteins.
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3.2. Genetic modifiers of somatic mosaicism
The analysis of CAG repeat instability has revealed a relationship between the severity of HD
phenotypes and the level of expansion‐biased somatic mosaicism in patients and mice. Thus,
HD mouse models in DNA repair deficient background have also been used to identify genetic
modifiers of somatic instability. In R6/1 and HdhQ111 mice, Msh2 deficiency was initially
reported to stabilize CAG repeat expansion in somatic tissues supporting that MSH2 also
drives instability toward expansions, like in germline cells [58, 59, 67].
Compared to the results obtained in Msh6‐deficient mice, the loss of both Msh3 alleles stabilize
CAG repeat tracts in somatic tissues suggesting that MSH3 acts as an enhancer of CAG
expansions‐biased somatic instability but not MSH6 [53, 64, 68]. Interestingly, the absence of
one allele of Msh3 is sufficient to decrease the somatic mosaicism in the striatum in contrast to
Msh2 supporting the idea that MSH3 levels modulate the degree of somatic instability and the
progression of HD disease [64]. Various degree of repeat instability in different HdhQ111 and
R6/1 mouse strains harboring the identical CAG repeat length suggest the existence of other
candidate factors as a source for strain‐specific variation in CAG repeat pattern [53, 55].
Interestingly, CAG repeat somatic mosaicism has been associated with Msh3 polymorphisms
and the level of MSH3 protein [53]. It has been reported that expansion changes were higher
in striatum and liver from R6/1 mice carrying the homozygous B6 Msh3 gene on a CBy genetic
background than mice carrying the homozygous CBy Msh3 gene on a B6 genetic background
(mice obtained by selective breeding). The loss of one B6 Msh3 allele in mice on a CBy genetic
background was sufficient to decrease CAG repeat instability, consistent with the results
obtained in Msh3‐deficient mice [53]. Thus, naturally occurring MSH3 protein polymorphisms
modify the dynamic of CAG repeat instability in mice and could modulate HD pathogenesis
in humans. Together, these data have shown that MSH2 and MSH3 proteins are strongly
required in the generation of somatic expansions.
To identify other genetic modifiers of CAG repeat instability, linkage analyses have been
performed in different HdhQ111 strains that showed CAG repeat instability variation [69]. A
single quantitative trait locus on chromosome 9 and particularly in MutL homolog Mlh1 gene
has been identified and associated with CAG repeat instability. Then, somatic instability has
been quantified in B6 HDHQ111 mice in the absence of one or two Mlh1 alleles. Although one
functional Mlh1 allele was still sufficient to generate high levels of repeat expansion, the loss
of both Mlh1 alleles abolished CAG repeat expansion in striatum suggesting that MLH1 was
required in somatic expansion. A second MutL homolog has been shown to act as an enhancer
of CAG repeat expansions. Indeed, expansion‐biased somatic mosaicism is reduced in Mlh3
heterozygous knockout mice and totally abolished in Mlh3 homozygous knockout mice
suggesting that MLH3 is a limiting factor on the process of expansion as reported for MSH3
protein [69].
Other DNA repair systems, such as BER and NER have also been investigated in R6/1 mice
to understand the somatic expansion variation observed between and within tissues. A loss
of Ogg1  suppressed CAG somatic expansions in 70% of R6/1 mice.  The same study has
reported that OGG1 initiated age‐dependent CAG repeat expansion mice, suggesting that
age‐dependent somatic expansion associated with HD occurs in the process of removing
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oxidized base lesions [70]. Deletion of Neil1 also reduced somatic expansions in male and
female R6/1 mice with a higher effect in different brain regions from male mice [61].  In
contrast to the results obtained in male germline, the absence of Csb and Fen1 did not affect
the dynamic of somatic instability in tissues suggesting that the role of Csb  is specific of
paternal contractions [65] and that Fen1 partially contributes to CAG repeat expansion upon
parental transmissions [66].
In conclusion, MSH2 and MSH3, partner proteins in the MutSβ MMR complex and MutLγ
(MLH1‐MLH3) are essential to promote expansions in HD mouse models suggesting that
MutSβ and MutLγ promote CAG expansion via the mismatch repair machinery. Furthermore,
CAG repeat expansion depends only partially on OGG1, NEIL1 and FEN1 proteins suggesting
that other DNA repair pathways are involved in the process of instability. Some genetic
modifiers such as Ogg1 and Fen1 impact CAG repeat instability in either somatic or germline
tissues, but not in both supporting that CAG repeat instability involves different genetic
players between tissues and may occur via different mechanisms. It has also shown that the
degree of somatic mosaicism appears to be modulated by Msh3 and Mlh1 variants in B6 mice
where CAG repeat expansion levels are the highest suggesting that somatic instability
variation observed in HD patients could be explained by DNA repair gene and/or protein
variants. Different expression levels of MSH3 and MLH3 have been identified in mouse strains
that exhibit different expansion frequencies supporting that the level of DNA repair proteins
might be correlated with the degree of CAG repeat instability. Other studies also support a
role for the stochiometries of DNA repair proteins in CAG repeat instability [4, 64, 71–73]. Few
data have reported the role of genetic factors in CAG repeat contractions mainly observed in
HD maternal transmissions and only Csb has been reported to promote contractions in paternal
transmissions. CSB protein could act on CAG repeat contraction via BER, NER, or chromatin
maintenance/remodeling activity independently of MSH2 protein.
4. Are genetic modifiers a therapeutic target?
The identification of genetic modifiers of underlying CAG repeat instability is important to
uncover novel therapeutic targets to slow down somatic instability and to decrease the
intergenerational expansions in favor of CAG repeat contractions to prevent the disease. It has
been reported that Msh2 alleles delay the accumulation of mutant protein and destruction of
mutant huntingtin in striatum and in specific neuron type from knock‐in HdhQ111 mice [58,
67]. Moreover, MLH1 also contributes to nuclear huntingtin and HD inclusion phenotypes [69].
Both data suggest that MSH2 and MLH1 may enhance the HD pathogenic process by modu‐
lating the somatic mosaicism in cooperation with MSH3 and MLH3 via the mismatch repair
pathway. Among MMR proteins, MSH3 and MLH3 are currently the most promising targets
to decrease CAG repeat expansions, thus delaying pathogenic process, given their minor roles
in the initiation of human cancer. To date, no drug has been identified to decrease the expres‐
sion of MLH3 and MSH3 protein and then the somatic instability. NElL1 and OGG1, two
glycosylases of the BER pathway partially contribute to CAG repeat expansions suggesting
that oxidative base damage is responsible of some CAG repeat expansions. Antioxidants may
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then decrease the expansion process. Mollersen and colleagues have suggested that several
antioxidants like anthocyanin decrease CAG repeat expansion in the brain from R6/1 male
mice [61]. The identification of new genetic factors involved in the formation of CAG repeat
contractions and a better understanding of expansion mechanisms are essential. Novel
therapies based on activating the DNA repair pathways promoting contractions might be
expected to have lower risk of side effects than therapies based on inhibiting the DNA repair
pathways that promote expansions.
5. Conclusion
The data summarized in this chapter have shown that cis‐elements such as DNA sequence
and transcription level, mismatch repair, base excision repair and nucleotide excision repair
proteins can modulate the pathogenic expansion‐biased somatic mosaicism and/or intergen‐
erational expansions contributing to the progression of HD phenotype. Natural polymor‐
phisms in Msh3 and Mlh1 genes have been associated with the degree of somatic expansions
in HD mice suggesting that MMR variants are involved in the somatic mosaicism variation
observed in HD patients and may modulate the disease severity and age of onset. Despite
a great advance on the understanding of instability,  the process remains complex.  Then,
further studies will be needed to assess how the various DNA repair and replication pro‐
teins collaborate all together in germline and/or somatic tissues to mediate CAG repeat ex‐
pansions. Moreover, future studies will be essential to identify new factors that promote
contractions in the germline and in somatic tissues, to reverse the HD expansion and to
stop the disease.
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